Tarsus Pharmaceuticals (TARS) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

Detailed price information for Tarsus Pharmaceuticals Inc (TARS-Q) from The Globe and Mail including charting and trades.

Tarsus Pharmaceuticals, Inc. (TARS) shares ended the last trading session 10.6% higher at $43.87. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

Discover what crypto is and how it works. A cryptocurrency is a digital form of money. They are digital assets created to be used to pay for goods and services. Cryptocurrencies can be used as a ...

On Friday, Tarsus Pharmaceuticals Inc (TARS) stock saw a modest uptick, ending the day at $39.41 which represents a slight increase of $0.52 or 1.34% from the prior close of $38.89. The stock opened ...

View Tarsus Pharmaceuticals, Inc. (TARS) current and estimated P/E ratio data provided by Seeking Alpha.

TARS Project Management has shifted its focus to India’s pre-IPO market, aiming to tap into the country's private sector opportunities. The firm has received support from ADIB, a leading ...

Barclays analyst Balaji Prasad maintained a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of ...

Harbor Capital Advisors Inc. raised its holdings in shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Free Report) by 57.5% in the third quarter, according to the company in its most recent filing ...

Tarsus Pharmaceuticals (TARS) announced the appointment of Elizabeth Yeu, M.D., as Chief Medical Officer, effective November 4, 2024. Dr. Yeu ...